CD34 and chronic myelogenous leukemia, BCR-ABL1 positive: Moreover, in-vivo experimental models using CML CD34-positive cells demonstrated that Hh inhibition in Smo knock-out mice, compromised both leukemic stem cell renewal and propagation [63].